HomeQuestion

Do you offer metformin to non-diabetic outpatients with acute SARS-CoV-2 infection to reduce the risk of long COVID based on the ACTIV-6 trial?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Do you use daptomycin interchangeably with staphylococcal beta-lactams for ease of dosing on discharge for patients with serious MSSA infections (endocarditis, bacteremias, etc)?

Would you consider using intravenous albumin to treat hypoalbuminemia in mucormycosis patients, given the correlation between low albumin levels and poor outcomes?

Do you treat diabetic foot osteomyelitis without surgical resection with a fixed 6-week antibiotic course, or do you shorten duration based on clinical and inflammatory marker response?

Do you typically narrow to penicillin or first-generation cephalosporin or continue broader anaerobic coverage for patients with cervical lymphadenitis requiring surgical drainage whose cultures grow only group A strep and gram stains only gram positive cocci?

What is the optimal therapy for laryngeal candidiasis in pregnancy?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.